Paris-Based May Health appoints Colby Holtshouse as President & CEO

• May Health announces Colby Holtshouse’s appointment
• Colby will take the position of President and CEO
• In her new role, she will be responsible for the REBALANCE study of the company

A clinical-stage medical device company, May Health made an announcement regarding the appointment of Colby Holtshouse as the President and CEO of the company. Colby is an experienced commercial leader who has a demonstrated track record in med tech, being dedicated towards enabling innovation, specifically for women's health.

A seasoned leader in healthcare industry, Colby is currently working with Chewonki Foundation as Member Board of Trustees since 2024. Simultaneously, she is also a Board Member at HealthifyMe for nearly 3 years now. Her career experience also includes Organon where she worked for almost 4 years, joining as Head of US Maternal Health Business Unit and later getting promoted to Global MedTech Commercial Lead.

May Health Chairman Dr. Robert Auerbach commented on the appointment, stating, “I am delighted to have Colby join and lead the company as we look to complete the REBALANCE study, a landmark investigational device exemption (IDE) clinical trial which is being conducted to support marketing authorization for our Ovarian Rebalancing procedure so that we can bring it to millions of women who experience PCOS-related infertility. Colby has deep experience bringing groundbreaking technologies to market, making her the ideal fit to spearhead May Health as we continue to validate the technology and drive towards commercialization.”

Furthermore, Sofinnova Partners Chairman and Managing Partner and May Health former Chairman Antoine Papiernik added, “May Health is pioneering a first-of-its-kind treatment for PCOS, a condition that affects 10% of women and presents serious health challenges, including infertility. We are excited to welcome Colby to guide the company in bringing this therapy to women around the world.”

Founded in 2017, May Health caters in the Medical Equipment Manufacturing industry with headquarters in Paris. Basically, the company is developing a modern approach to PCOS, earlier known as AblaCare.